Unravelling the Complexity of Colorectal Cancer: Heterogeneity, Clonal Evolution, and Clinical Implications.

biomarkers clonal evolution ctDNA metastatic colorectal cancer tumor heterogeneity

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
08 Aug 2023
Historique:
received: 13 07 2023
revised: 01 08 2023
accepted: 02 08 2023
medline: 26 8 2023
pubmed: 26 8 2023
entrez: 26 8 2023
Statut: epublish

Résumé

Colorectal cancer (CRC) is a global health concern and a leading cause of death worldwide. The disease's course and response to treatment are significantly influenced by its heterogeneity, both within a single lesion and between primary and metastatic sites. Biomarkers, such as mutations in

Identifiants

pubmed: 37627048
pii: cancers15164020
doi: 10.3390/cancers15164020
pmc: PMC10452468
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Références

Pathology. 2018 Jun;50(4):389-401
pubmed: 29752127
Lancet Oncol. 2015 May;16(5):499-508
pubmed: 25877855
Proc Natl Acad Sci U S A. 2015 Sep 1;112(35):10995-1000
pubmed: 26286987
Ann Oncol. 2020 Oct;31(10):1291-1305
pubmed: 32702383
Annu Rev Pathol. 2011;6:479-507
pubmed: 21090969
Cancers (Basel). 2021 Jan 05;13(1):
pubmed: 33466373
Nat Biotechnol. 2022 Dec;40(12):1794-1806
pubmed: 36203011
Clin Cancer Res. 2014 Oct 15;20(20):5322-30
pubmed: 25139339
Genome Med. 2013 Aug 13;5(8):70
pubmed: 23953663
Nature. 2022 Nov;611(7936):603-613
pubmed: 36352230
Nat Genet. 2015 Mar;47(3):209-16
pubmed: 25665006
Clin Colorectal Cancer. 2022 Sep;21(3):267-271
pubmed: 35039233
J Clin Oncol. 2008 Sep 1;26(25):4217-9
pubmed: 18757341
Genome Biol. 2014 Aug 28;15(8):454
pubmed: 25164765
Cancers (Basel). 2019 Oct 08;11(10):
pubmed: 31597339
Oncotarget. 2018 Apr 17;9(29):20761-20768
pubmed: 29755687
Nat Med. 2015 Nov;21(11):1350-6
pubmed: 26457759
EMBO Mol Med. 2017 Jul;9(7):869-879
pubmed: 28468934
Clin Cancer Res. 2021 Oct 15;27(20):5586-5594
pubmed: 33926918
Cell. 2017 Feb 9;168(4):613-628
pubmed: 28187284
Oncotarget. 2016 Mar 1;7(9):10051-63
pubmed: 26840267
PLoS Genet. 2016 Jul 29;12(7):e1006225
pubmed: 27472274
Nat Commun. 2017 May 31;8:15657
pubmed: 28561046
Ann Oncol. 2018 Jan 1;29(1):44-70
pubmed: 29155929
Nat Commun. 2020 Sep 2;11(1):4301
pubmed: 32879317
J Clin Oncol. 2015 Mar 1;33(7):692-700
pubmed: 25605843
PLoS One. 2013 Dec 18;8(12):e84604
pubmed: 24367680
N Engl J Med. 2020 Sep 24;383(13):1207-1217
pubmed: 32955176
Nat Genet. 2016 Mar;48(3):238-244
pubmed: 26780609
JAMA Oncol. 2019 Mar 1;5(3):343-350
pubmed: 30476968
Cancer Discov. 2014 Jun;4(6):650-61
pubmed: 24801577
Science. 2013 Mar 29;339(6127):1546-58
pubmed: 23539594
Nature. 2017 Mar 29;543(7647):676-680
pubmed: 28358093
Nature. 2012 Jan 26;483(7387):100-3
pubmed: 22281684
CA Cancer J Clin. 2021 May;71(3):209-249
pubmed: 33538338
Oncol Rep. 2017 Feb;37(2):785-792
pubmed: 28000889
Gastroenterology. 2023 Apr;164(5):841-846
pubmed: 36702361
Theranostics. 2023 Mar 5;13(5):1607-1631
pubmed: 37056571
Ann Oncol. 2021 Dec;32(12):1496-1510
pubmed: 34411693
J Clin Oncol. 2020 Aug 20;:JCO2001225
pubmed: 32816630
PLoS Genet. 2016 Feb 18;12(2):e1005778
pubmed: 26890883
Cancer Discov. 2018 Apr;8(4):428-443
pubmed: 29431699
Nat Med. 2015 Jul;21(7):795-801
pubmed: 26030179
Am Soc Clin Oncol Educ Book. 2022 Apr;42:1-10
pubmed: 35503983
Cancer Discov. 2017 Jul 20;:
pubmed: 28729406
J Natl Compr Canc Netw. 2021 Mar 02;19(3):329-359
pubmed: 33724754
Cell Stem Cell. 2020 Apr 2;26(4):569-578.e7
pubmed: 32169167
Oral Oncol. 2013 Mar;49(3):211-5
pubmed: 23079694
Eur J Cancer. 2022 Sep;172:326-328
pubmed: 35820242
J Pathol. 2017 Jan;241(1):57-66
pubmed: 27741368
Am J Cancer Res. 2017 Sep 01;7(9):1978-1989
pubmed: 28979819
N Engl J Med. 2019 Oct 24;381(17):1632-1643
pubmed: 31566309
J Clin Oncol. 2021 Feb 1;39(4):285-294
pubmed: 33356422
Lancet. 2012 May 19;379(9829):1893-901
pubmed: 22608338
Cancer Discov. 2016 Sep;6(9):963-71
pubmed: 27325282
N Engl J Med. 2015 Aug 20;373(8):726-36
pubmed: 26287849
Ann Oncol. 2014 Sep;25 Suppl 3:iii1-9
pubmed: 25190710
BMC Cancer. 2018 Jul 20;18(1):752
pubmed: 30029640
Oncologist. 2022 Jul 5;27(7):536-e553
pubmed: 35325211
Nat Genet. 2020 Nov;52(11):1208-1218
pubmed: 33128048
JCO Precis Oncol. 2021 Nov;5:1082-1087
pubmed: 34994629
Gut. 2017 Dec;66(12):2132-2140
pubmed: 27609830
Anticancer Agents Med Chem. 2012 Feb;12(2):163-71
pubmed: 22043994
Mol Oncol. 2019 Sep;13(9):1827-1835
pubmed: 31322322
Science. 1976 Oct 1;194(4260):23-8
pubmed: 959840
J Clin Oncol. 2012 Oct 1;30(28):3499-506
pubmed: 22949147
Trends Cancer. 2023 Jun;9(6):490-502
pubmed: 37059687
J Clin Oncol. 2022 Aug 20;40(24):2846-2857
pubmed: 35839443
Mol Oncol. 2017 Feb;11(2):124-139
pubmed: 28145097
Cancer Discov. 2020 Aug;10(8):1129-1139
pubmed: 32430388
J Pathol Clin Res. 2016 Apr 15;2(3):166-74
pubmed: 27499925
Ann Oncol. 2023 Jan;34(1):10-32
pubmed: 36307056
Cancer Cell. 2018 Jul 9;34(1):148-162.e7
pubmed: 29990497
Cold Spring Harb Perspect Med. 2018 May 1;8(5):
pubmed: 28710260
Cancer Treat Rev. 2019 Feb;73:41-53
pubmed: 30616224
PLoS One. 2015 May 14;10(5):e0126670
pubmed: 25974029
Nat Rev Immunol. 2021 Oct;21(10):653-667
pubmed: 33911231
Br J Cancer. 2010 Oct 12;103(8):1139-43
pubmed: 20877357
Cancer Treat Rev. 2023 Jul;118:102583
pubmed: 37331179
Curr Biol. 2012 Sep 11;22(17):R762-71
pubmed: 22975007
Brief Bioinform. 2021 May 20;22(3):
pubmed: 34020548
Future Oncol. 2017 Jan;13(2):135-144
pubmed: 27578453
Nature. 2017 May 11;545(7653):187-192
pubmed: 28355176
J Clin Oncol. 2015 Dec 1;33(34):4023-31
pubmed: 26392102
Cancer Discov. 2012 Mar;2(3):227-35
pubmed: 22448344
Exp Mol Med. 2018 Aug 7;50(8):1-14
pubmed: 30089861
Clin Cancer Res. 2016 Aug 15;22(16):4095-104
pubmed: 27151745
Nature. 2022 Nov;611(7937):744-753
pubmed: 36289336
Science. 2016 Apr 8;352(6282):189-96
pubmed: 27124452
Lancet. 1978 Feb 4;1(8058):245-7
pubmed: 74668
Nat Genet. 2016 Jul;48(7):758-67
pubmed: 27182968
J Clin Oncol. 2023 May 10;41(14):2628-2637
pubmed: 36763936
Clin Cancer Res. 2021 May 1;27(9):2515-2522
pubmed: 33602686
Int J Cancer. 2015 Jan 1;136(1):83-90
pubmed: 24806288
J Clin Pathol. 2018 Feb;71(2):110-116
pubmed: 28942428
Ann Oncol. 2017 Dec 1;28(12):2943-2949
pubmed: 28945877
Sci Rep. 2022 Dec 14;12(1):21615
pubmed: 36517625
Clin Colorectal Cancer. 2018 Mar;17(1):e39-e44
pubmed: 28789931
Cancer. 1992 Sep 15;70(6 Suppl):1727-31
pubmed: 1516027
Eur J Cancer. 2015 Jul;51(10):1243-52
pubmed: 25937522
Br J Cancer. 2018 May;118(11):1410-1418
pubmed: 29844449
Cell Rep. 2014 Feb 13;6(3):514-27
pubmed: 24462293
Oncologist. 2011;16(9):1239-49
pubmed: 21742964
Proc Natl Acad Sci U S A. 2007 Nov 20;104(47):18654-9
pubmed: 18003927
Nat Med. 2022 Aug;28(8):1612-1618
pubmed: 35915157
BMC Gastroenterol. 2019 Oct 10;19(1):164
pubmed: 31601167
N Engl J Med. 2023 Jan 5;388(1):44-54
pubmed: 36546659
N Engl J Med. 2013 Sep 12;369(11):1023-34
pubmed: 24024839
Cancer Discov. 2017 Jun;7(6):610-619
pubmed: 28363909

Auteurs

Nadia Saoudi González (N)

Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain.
Oncology Department, Vall d'Hebron Hospital, 08035 Barcelona, Spain.

Francesc Salvà (F)

Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain.
Oncology Department, Vall d'Hebron Hospital, 08035 Barcelona, Spain.

Javier Ros (J)

Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain.
Oncology Department, Vall d'Hebron Hospital, 08035 Barcelona, Spain.

Iosune Baraibar (I)

Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain.
Oncology Department, Vall d'Hebron Hospital, 08035 Barcelona, Spain.

Marta Rodríguez-Castells (M)

Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain.
Oncology Department, Vall d'Hebron Hospital, 08035 Barcelona, Spain.

Ariadna García (A)

Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain.

Adriana Alcaráz (A)

Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain.
Oncology Department, Vall d'Hebron Hospital, 08035 Barcelona, Spain.

Sharela Vega (S)

Oncology Department, Vall d'Hebron Hospital, 08035 Barcelona, Spain.

Sergio Bueno (S)

Oncology Department, Vall d'Hebron Hospital, 08035 Barcelona, Spain.

Josep Tabernero (J)

Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain.
Oncology Department, Vall d'Hebron Hospital, 08035 Barcelona, Spain.

Elena Elez (E)

Vall d'Hebron Institute of Oncology, 08035 Barcelona, Spain.
Oncology Department, Vall d'Hebron Hospital, 08035 Barcelona, Spain.

Classifications MeSH